or Try an Advanced Search...

    Technical Analysis for MLYS - Mineralys Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 13.45 0.52% 0.07
    MLYS closed up 0.52 percent on Friday, November 1, 2024, on 1.32 times normal volume.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical MLYS trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Fell Below 20 DMA Bearish 0.52%
    New Downtrend Bearish 0.52%
    200 DMA Support Bullish 0.52%
    50 DMA Support Bullish 0.52%
    Hammer Candlestick Bullish 0.52%
    Lizard Bullish Bullish Day Trade Setup 0.52%
    Older End-of-Day Signals for MLYS ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support about 19 hours ago
    Down 1% about 20 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    Fell Below Lower Bollinger Band about 23 hours ago
    Lizard Bullish Entry about 23 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MLYS Chart by TradingView
    Basic chart:

    Profile

    Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension

    Is MLYS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 30 Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
    Oct 22 Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024
    Oct 20 We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate
    Sep 25 Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
    Sep 17 Mineralys In Hypertension: Upcoming Catalysts And Strong Positioning
    Aug 28 Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference
    Aug 14 Mineralys Therapeutics, Inc. (MLYS) Q2 2024 Earnings Call Transcript
    Aug 13 Mineralys Therapeutics GAAP EPS of -$0.83 misses by $0.12
    Aug 13 Mineralys Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
    Aug 13 Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
    See more MLYS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.905
    52 Week Low 5.86
    Average Volume 133,643
    200-Day Moving Average 12.71
    50-Day Moving Average 12.71
    20-Day Moving Average 13.73
    10-Day Moving Average 13.71
    Average True Range 0.56
    RSI (14) 51.46
    ADX 34.21
    +DI 18.51
    -DI 19.40
    Chandelier Exit (Long, 3 ATRs) 12.78
    Chandelier Exit (Short, 3 ATRs) 14.23
    Upper Bollinger Bands 14.19
    Lower Bollinger Band 13.27
    Percent B (%b) 0.2
    BandWidth 6.70
    MACD Line 0.27
    MACD Signal Line 0.38
    MACD Histogram -0.1082
    Fundamentals Value
    Market Cap 552.86 Million
    Num Shares 41.1 Million
    EPS -1.38
    Price-to-Earnings (P/E) Ratio -9.75
    Price-to-Sales 0.00
    Price-to-Book 2.18
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 14.40
    Resistance 3 (R3) 14.39 14.06 14.24
    Resistance 2 (R2) 14.06 13.82 14.07 14.18
    Resistance 1 (R1) 13.76 13.67 13.60 13.77 14.13
    Pivot Point 13.43 13.43 13.35 13.44 13.43
    Support 1 (S1) 13.13 13.19 12.97 13.14 12.77
    Support 2 (S2) 12.80 13.04 12.81 12.72
    Support 3 (S3) 12.50 12.80 12.66
    Support 4 (S4) 12.51